Innovation
7 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,837 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 1 |
Social engagement
Social engagement: 2.8K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Lumira Ventures, Leaps by Bayer.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 1 | 11% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 2 | 22% |
Recent activity
13 Feb 2026
Event
IO360
10 Feb 2026
Event
IO360
12 Aug 2025
Event
Immuno-Oncology Summit